Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
Neurol India
;
1999 Sep; 47(3): 206-9
Article
in English
| IMSEAR
| ID: sea-120389
ABSTRACT
Twenty seven patients with hemifacial spasm (HFS) and sixteen patients with blepharospasm (BS) having mean Jankovic disability rating scale score of 2.56+0.58 SD and 2.81+0.54 SD, respectively, were treated with botulinum toxin A (BTX-A) injections. The total number of injection sessions were ninety one with relief response in 98.91%. The mean improvement in function scale score was 3.78+0.64 SD and 3.29+1.07 SD respectively, in HFS and BS groups. The clinical benefit induced by botulinum toxin lasted for a mean of 4.46+3.11 SD (range 2 to 13) months in HFS group and 2.66+1.37 SD (range 1 to 6) months, in BS groups. Transient ptosis was seen in 4.39% of total ninety one injection sessions. These findings show that local botulinum toxin treatment provides effective, safe and long lasting relief of spasms.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Time Factors
/
Blepharospasm
/
Aged
/
Humans
/
Follow-Up Studies
/
Botulinum Toxins, Type A
/
Adult
/
Hemifacial Spasm
/
Middle Aged
/
Neuromuscular Agents
Type of study:
Observational study
/
Prognostic study
Language:
English
Journal:
Neurol India
Year:
1999
Type:
Article
Similar
MEDLINE
...
LILACS
LIS